Not checked for notices yet.
Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies
Sinead Toomey, Alexander J. Eustace, Joanna Fay and 21 more
Breast Cancer Research · 2017
Cited by papers we hold 1
- PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer · 2022No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.